skip to content

Innovation

Driven by our passion for what we do, our autonomy in how we find solutions, and the strength of our R&D structure we can take on the most complex challenges in healthcare.

Innovation across the Roche Group

Our close strategic partnerships across the Group, and our diverse mix of autonomous innovation engines gives us a rich diversity of expertise and scientific thinking, as we seek to discover and develop solutions to the biggest questions in healthcare today.

13 billion

CHF invested in R&D in 2024

17

countries with Roche innovation centers

>100,000

dedicated employees

Roche Group Innovation Engines

To discover and develop the next breakthroughs, we have built a network of independent innovation engines around the world.

Explore our structure
Decorative Illustration
Decorative Illustration

Innovation process

It's a long way from an idea to medical innovation. Here's how we get there.

Discover our processes

With patient and societal health needs in mind, we leverage our passion and curiosity for science to create revolutionary medicines that can change patients' lives.

Hans Clevers

Head of Roche Pharma Research and Early Development (pRED)

Great people join us because they want to work on the hardest problems in science.

Aviv Regev

Head of Genentech Research and Early Development (gRED)

The development of transformative therapeutics and diagnostics is a tough business... This is something that the unique structure of the Roche Group really provides.

Palani Kumaresan

Head of Roche Diagnostics Solutions

The benefit of being part of the Roche Group is the huge amount of expertise, experience and resources that we have across the company.

Tom Albert

Global Head of Research and Early Development, Roche Diagnostics Solutions

It is the tremendous diversity of thought and the diversity of decision making within the Roche Group, and across our partnerships, that leads to the development of groundbreaking therapies and diagnostics for patients.

James Sabry

Global Head of Roche Pharma Partnering

Close-up of a metal key inserted in a wooden locker, with a keychain labeled "4.13." The scene is brightly lit, evoking a sense of security and order.

Ethical standards

Questions inevitably arise as we explore the potential of cutting-edge technologies. We are committed to adhering to the highest ethical standards in research and development.

How do we meet them

Partnering

Alongside our unique Group structure, our strong network of external partners, drives the creativity and innovation needed for breakthrough research and development

Get to know partnering
A scientist wearing safety goggles and gloves uses a pipette in a lab. The focus is on precision and care, with a calm and professional atmosphere.
See all stories
A man wearing glasses and a black vest sits in front of an audience, engaging with the crowd.

External innovation opens new doors for advancing science

Global Head of Pharma Partnering James Sabry is excited to embrace the potential of external innovation and innovative partners.

An illustration showing individuals in a desert, featuring sparse vegetation and a few trees against a sandy backdrop.

Joining forces in neuroscience

Neurological disorders pose some of the greatest challenges and areas of unmet medical need. We are joining forces with others who are studying these challenges.

Illustration of a data

Data can change your life; it probably already has

How data can improve and save lives, and why it matters during the COVID-19 crisis and beyond.

Discover more

Careers

Find jobs and learn more about exciting career opportunities at Roche, one of the world's leading research-based healthcare companies.

Focus areas
Solutions

Finding innovative solutions for unmet medical needs is at the heart of what we do. Our ideas and research help save lives.

How can immuno-oncology change the care for cancer patients?

In order to deliver on Foundation Medicine’s mission to bring precision medicine to patients at the highest quality, and as quickly as possible, we need to push the boundaries of R&D.